Ryosuke Imai

574 total citations
52 papers, 268 citations indexed

About

Ryosuke Imai is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Neurology. According to data from OpenAlex, Ryosuke Imai has authored 52 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Pulmonary and Respiratory Medicine, 13 papers in Epidemiology and 10 papers in Neurology. Recurrent topics in Ryosuke Imai's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers), Respiratory Support and Mechanisms (9 papers) and Pleural and Pulmonary Diseases (6 papers). Ryosuke Imai is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers), Respiratory Support and Mechanisms (9 papers) and Pleural and Pulmonary Diseases (6 papers). Ryosuke Imai collaborates with scholars based in Japan, United States and United Kingdom. Ryosuke Imai's co-authors include Torahiko Jinta, Naoki Nishimura, Manabu Murakami, Atsushi Kitamura, Tomohide Tamura, Yasushi Hasebe, Takakazu Higuchi, Sadamu Okada, Shunichi Uchiyama and Tomoaki Nakamura and has published in prestigious journals such as SHILAP Revista de lepidopterología, ACS Nano and CHEST Journal.

In The Last Decade

Ryosuke Imai

45 papers receiving 260 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryosuke Imai Japan 9 91 66 49 42 37 52 268
Josep Bringué Spain 8 164 1.8× 58 0.9× 33 0.7× 30 0.7× 46 1.2× 8 258
Samuel Short United States 6 78 0.9× 43 0.7× 39 0.8× 19 0.5× 38 1.0× 15 243
Chuen Wen Tan Singapore 9 50 0.5× 139 2.1× 101 2.1× 66 1.6× 32 0.9× 31 366
Shine Raju United States 9 129 1.4× 80 1.2× 28 0.6× 17 0.4× 34 0.9× 19 278
Nicol Bernardinello Italy 12 281 3.1× 46 0.7× 56 1.1× 57 1.4× 48 1.3× 48 406
Jennifer Clarke Ireland 8 49 0.5× 113 1.7× 65 1.3× 39 0.9× 32 0.9× 11 239
Faisal Siddiqui United States 11 67 0.7× 71 1.1× 42 0.9× 19 0.5× 26 0.7× 31 319
Fatemeh Jafari Iran 10 40 0.4× 77 1.2× 36 0.7× 56 1.3× 22 0.6× 34 354
Michele Bellino Italy 11 61 0.7× 112 1.7× 79 1.6× 20 0.5× 44 1.2× 45 407
Suqin Ben China 11 144 1.6× 41 0.6× 25 0.5× 67 1.6× 79 2.1× 21 451

Countries citing papers authored by Ryosuke Imai

Since Specialization
Citations

This map shows the geographic impact of Ryosuke Imai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryosuke Imai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryosuke Imai more than expected).

Fields of papers citing papers by Ryosuke Imai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryosuke Imai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryosuke Imai. The network helps show where Ryosuke Imai may publish in the future.

Co-authorship network of co-authors of Ryosuke Imai

This figure shows the co-authorship network connecting the top 25 collaborators of Ryosuke Imai. A scholar is included among the top collaborators of Ryosuke Imai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryosuke Imai. Ryosuke Imai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kinoshita, Ryo, Maki Shimada, Ryosuke Imai, et al.. (2025). Intravenous Administration of Liposomes Encapsulating Oleanolic Acid Ameliorates Lung Injury Caused by Air Pollutants. Environmental Toxicology. 41(2). 121–130.
2.
Imai, Ryosuke, Sydney B. Montesi, Anjali Singh, et al.. (2025). Association of Anti-Ro52 Seropositive Interstitial Lung Disease With a Higher Risk of Disease Progression and Mortality. CHEST Journal. 168(4). 954–966. 3 indexed citations
3.
Imai, Ryosuke, et al.. (2025). Lung Function Changes Across the Menopausal Transition. CHEST Journal. 169(3). 710–722.
4.
Imai, Ryosuke, Takayuki Niitsu, Monica Yun Liu, et al.. (2025). Comparison of Corticosteroid Regimens for COVID-19 and Non-COVID-19 ARDS. SHILAP Revista de lepidopterología. 3(4). 100207–100207.
5.
Imai, Ryosuke, et al.. (2023). Sarcoidosis or sarcoid-like reaction with mediastinal lymphadenopathy in patients after breast cancer surgery. Respiratory Investigation. 61(4). 398–404. 2 indexed citations
6.
Imai, Ryosuke & Atsushi Kitamura. (2023). Successful treatment with atezolizumab in a haemodialysis patient with large cell neuroendocrine carcinoma. SHILAP Revista de lepidopterología. 11(8). e01193–e01193. 3 indexed citations
7.
Kitamura, Atsushi, Manabu Murakami, Ryosuke Imai, et al.. (2022). A case of a thoracic mass negative on thoracentesis diagnosed by cryobiopsy from the visceral pleura. SHILAP Revista de lepidopterología. 10(11). e01050–e01050. 1 indexed citations
8.
Nakamura, Tomoaki, Ryosuke Imai, & Naoki Nishimura. (2022). A Case of Nonsmall-Cell Lung Cancer with Anaphylaxis after 41 Courses of Pembrolizumab along with Adrenal Insufficiency as an Immune-Related Adverse Event. SHILAP Revista de lepidopterología. 15(3). 804–808. 4 indexed citations
9.
Imai, Ryosuke, et al.. (2022). Progressive pulmonary fibrosis due to diffuse alveolar damage in a COVID‐19‐infected autopsy case. SHILAP Revista de lepidopterología. 10(4). e0934–e0934. 4 indexed citations
10.
Imai, Ryosuke, et al.. (2021). Ultrasonic humidifier lung as a mimic of COVID‐19. Respirology Case Reports. 9(6). e00761–e00761. 3 indexed citations
11.
Nishimura, Naoki, Ryosuke Imai, Manabu Murakami, et al.. (2021). Identification of patients with COVID-19 who are optimal for methylprednisolone pulse therapy. Multidisciplinary Respiratory Medicine. 16(1). 781–781. 12 indexed citations
12.
Imai, Ryosuke, et al.. (2021). Steroid resistance and rebound phenomena in patients with COVID-19. Respiratory Investigation. 59(5). 608–613. 8 indexed citations
13.
Kitamura, Atsushi, Ryosuke Imai, Manabu Murakami, et al.. (2021). Reproducibility of peripheral branches in virtual bronchoscopic navigation using VINCENT and LungPoint software for peripheral lung lesions. Respiratory Investigation. 59(6). 772–776. 5 indexed citations
14.
Imai, Ryosuke, Naoki Nishimura, Osamu Takahashi, & Tomohide Tamura. (2021). High‐resolution computed tomography for the prediction of mortality in acute respiratory distress syndrome: A retrospective cohort study. Health Science Reports. 4(4). e418–e418. 6 indexed citations
15.
Imai, Ryosuke, et al.. (2021). Anti‐TIF1γ antibody‐positive dermatomyositis associated with durvalumab administration in a patient with lung and oesophageal cancers. Respirology Case Reports. 9(4). e00736–e00736. 4 indexed citations
16.
Imai, Ryosuke, Atsushi Mizuno, Mitsunori Miyashita, et al.. (2021). Bereaved Family Members' Perceived Care at the End of Life for Patients with Noncancerous Respiratory Diseases. SHILAP Revista de lepidopterología. 2(1). 265–271. 1 indexed citations
17.
Murakami, Manabu, et al.. (2020). High‐dose, short‐term corticosteroids for ARDS caused by COVID‐19: a case series. Respirology Case Reports. 8(6). e00596–e00596. 43 indexed citations
18.
Murakami, Manabu, et al.. (2020). Unilateral pleural effusion with capillary haemangioma. Respirology Case Reports. 8(6). e00613–e00613. 1 indexed citations
19.
Imai, Ryosuke, et al.. (2020). Left ventricular dysfunction in an idiopathic pulmonary fibrosis patient on nintedanib. Respirology Case Reports. 8(2). e00533–e00533. 2 indexed citations
20.
Imai, Ryosuke, et al.. (2020). Diffuse large B‐cell lymphoma presenting with cavitary lung disease. Respirology Case Reports. 8(5). e00584–e00584. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Josep Bringué Breakdown of academic impact, for papers by Samuel Short Breakdown of academic impact, for papers by Chuen Wen Tan Breakdown of academic impact, for papers by Shine Raju Breakdown of academic impact, for papers by Nicol Bernardinello Breakdown of academic impact, for papers by Jennifer Clarke Breakdown of academic impact, for papers by Faisal Siddiqui Breakdown of academic impact, for papers by Fatemeh Jafari Breakdown of academic impact, for papers by Michele Bellino Breakdown of academic impact, for papers by Suqin Ben
Rankless by CCL
2026